Correlation Between Anika Therapeutics and Nanomix

Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Nanomix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Nanomix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anika Therapeutics and Nanomix, you can compare the effects of market volatilities on Anika Therapeutics and Nanomix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Nanomix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Nanomix.

Diversification Opportunities for Anika Therapeutics and Nanomix

-0.94

Correlation Coefficient

Anika Therapeutics  Nanomix

Pay attention - limited upside

The 3 months correlation between Anika and Nanomix is -0.94. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Nanomix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanomix and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Nanomix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanomix has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Nanomix go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Nanomix

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Nanomix. But the stock apears to be less risky and, when comparing its historical volatility, Anika Therapeutics is 2.99 times less risky than Nanomix. The stock trades about -0.09 of its potential returns per unit of risk. The Nanomix is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Nanomix on September 12, 2024 and sell it today you would earn a total of  0.01  from holding Nanomix or generate 100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Anika Therapeutics  vs.  Nanomix

Anika Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Nanomix

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nanomix are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Nanomix showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anika Therapeutics and Nanomix

The main advantage of trading using opposite Anika Therapeutics and Nanomix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Nanomix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanomix will offset losses from the drop in Nanomix's long position.

The idea behind Anika Therapeutics and Nanomix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.